Immunotherapy

OCT 10, 2026 · JOURNAL ARTICLE

Real-world efficacy and safety of neoadjuvant immunochemotherapy in patients with triple-negative breast cancer

Immunotherapy

Aim To evaluate the real‑world efficacy and safety of adding programmed cell death protein 1 (PD-1) inhibitors to neoadjuvant chemotherapy in Chinese patients with triple‑negative

SEP 5, 2026 · JOURNAL ARTICLE

Cancer vaccines as targeted therapies: translational advances and challenges

Immunotherapy

This is a narrative review that raises questions and summarizes progress rather than reporting empirical results with effect sizes or comparative outcomes to answer them.